These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37854083)

  • 1. Use of Oral Empagliflozin to Obtain Optimal Blood Sugar Levels for Conducting
    Mahato A; Jain A; Prakash VS; Nair R; Joshi R; Paliwal D; Tiwari A; Khandpur S; Singh H
    World J Nucl Med; 2023 Sep; 22(3):191-195. PubMed ID: 37854083
    [No Abstract]   [Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test.
    Rallapeta RP; Manthri RG; Kalawat T; Sachan A; Lakshmi AY; Hulikal N
    Indian J Nucl Med; 2020; 35(2):110-115. PubMed ID: 32351264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
    Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
    Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hyperglycemia on brain and liver
    Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
    Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.
    Povoski SP; Murrey DA; Smith SM; Martin EW; Hall NC
    BMC Cancer; 2014 Jun; 14():453. PubMed ID: 24942656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Blood Glucose Management Before
    Pijl JP; Glaudemans AWJM; Gheysens O; Slart RHJA; Kwee TC
    J Nucl Med; 2023 Aug; 64(8):1287-1294. PubMed ID: 37414447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
    Mirpour S; Meteesatien P; Khandani AH
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):71-7. PubMed ID: 22088805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can pain influence the severity of findings of an (18)F-FDG PET/CT scan in loosening hip arthroplasty?
    Pianou NK; Pneumaticos SG; Vlachos L; Chatziioannou SN
    Hell J Nucl Med; 2011; 14(3):318-9. PubMed ID: 22087460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Calabro' A; Abdelhafez YG; Triumbari EKA; Spencer BA; Chen MS; Albano D; Cassim CR; Bertagna F; Dondi F; Cherry SR; Badawi RD; Sen F; Nardo L
    BMC Med Imaging; 2023 Jan; 23(1):9. PubMed ID: 36627570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis.
    Ioannou S; Chatziioannou S; Pneumaticos SG; Zormpala A; Sipsas NV
    BMC Infect Dis; 2013 Feb; 13():73. PubMed ID: 23388066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
    Pant V; Sen IB; Soin AS
    Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [
    Bajorat R; Kurth J; Stenzel J; Vollmar B; Krause BJ; Reuter DA; Schuerholz T; Bergt S
    Mol Imaging Biol; 2022 Jun; 24(3):466-478. PubMed ID: 34779968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative
    de Heer EC; Brouwers AH; Boellaard R; Sluiter WJ; Diercks GFH; Hospers GAP; de Vries EGE; Jalving M
    EJNMMI Res; 2018 Nov; 8(1):101. PubMed ID: 30460579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.